Who Owns BioNexus Gene Lab Corp. (BGLC)?Hedge Fund & Institutional Holders

$2.24-0.01 (-0.44%)HealthcareNASDAQ

Institutional Holders

4

as of QNaN NaN

Total Institutional Value

$36.8B

% of Float Held

QoQ Change in Holders

+4 / -0

Price History

$1.94$4.24$6.54$8.84$11.14Oct 24Jun 25Mar 26

BGLC — Biggest Institutional Buyers This Quarter

FundShares AddedValue% of Portfolio
CITADEL ADVISORS LLCNew99K$23.3B0.00%
TWO SIGMA INVESTMENTS, LPNew36K$8.4B0.02%
GEODE CAPITAL MANAGEMENT, LLCNew24K$5.0B0.00%
UBS Group AGNew4$1.0M0.00%

Top Institutional Holders(QNaN NaN)

#FundSharesValue% of PortfolioQoQ Share Change
1CITADEL ADVISORS LLC98,768$23.3B0.00%New
2TWO SIGMA INVESTMENTS, LP35,532$8.4B0.02%New
3GEODE CAPITAL MANAGEMENT, LLC23,681$5.0B0.00%New
4UBS Group AG4$1.0M0.00%New

Similar Stocks by Institutional Ownership

As of QNaN NaN, 4 institutional investors hold BGLC (BioNexus Gene Lab Corp.). The largest holder is CITADEL ADVISORS LLC with $23.3B in shares. This quarter, 4 institutions opened new positions and 0 closed their positions.

Frequently Asked Questions

How many hedge funds own BGLC?

As of QNaN NaN, 4 institutional investors report holding BGLC (BioNexus Gene Lab Corp.) in their 13F filings.

Who is the largest institutional holder of BGLC?

The largest institutional holder of BGLC is CITADEL ADVISORS LLC with $23.3B in shares.

Is institutional ownership of BGLC increasing or decreasing?

This quarter, 4 institutions opened new positions in BGLC and 0 closed their positions.